News Alert now
Tuesday, 30 April 2019
The obscure advisory committees at the heart of the U.S. drug pricing debate
Expectations were high last year for three new migraine drugs hitting the market from Amgen Inc, Eli Lilly and Co and Teva Pharmaceutical Industries.
from Reuters: U.S. https://reut.rs/2VwZsGQ
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment